Sood AK - Search Results

1

Uptake and Outcomes of Neoadjuvant Chemotherapy Among US Patients With Less Common Epithelial Ovarian Carcinomas.

Matsuo K, Matsuzaki S, Maeda M, Rau AR, Yoshihara K, Tamura R, Shimada M, Machida H, Mikami M, Klar M, Roman LD, Wright JD, Sood AK, Gershenson DM. Matsuo K, et al. Among authors: sood ak. JAMA Netw Open. 2023 Jun 1;6(6):e2318602. doi: 10.1001/jamanetworkopen.2023.18602. JAMA Netw Open. 2023. PMID: 37326992 Free PMC article.

2

Functional role of matrix metalloproteinases in ovarian tumor cell plasticity.

Sood AK, Fletcher MS, Coffin JE, Yang M, Seftor EA, Gruman LM, Gershenson DM, Hendrix MJ. Sood AK, et al. Am J Obstet Gynecol. 2004 Apr;190(4):899-909. doi: 10.1016/j.ajog.2004.02.011. Am J Obstet Gynecol. 2004. PMID: 15118611

3

Biological significance of focal adhesion kinase in ovarian cancer: role in migration and invasion.

Sood AK, Coffin JE, Schneider GB, Fletcher MS, DeYoung BR, Gruman LM, Gershenson DM, Schaller MD, Hendrix MJ. Sood AK, et al. Am J Pathol. 2004 Oct;165(4):1087-95. doi: 10.1016/S0002-9440(10)63370-6. Am J Pathol. 2004. PMID: 15466376 Free PMC article.

4

Fifth International Conference on Ovarian Cancer: challenges and opportunities.

Sood AK, Abu-Rustum NR, Barakat RR, Bodurka DC, Brown J, Donato ML, Poynor EA, Wolf JK, Gershenson DM. Sood AK, et al. Gynecol Oncol. 2005 Jun;97(3):916-23. doi: 10.1016/j.ygyno.2005.03.013. Gynecol Oncol. 2005. PMID: 15907981

5

Selected highlights from the 5th International Conference on Ovarian Cancer. Houston, TX, USA, 1-4 December 2004.

Sood AK, Coleman RL, Wolf JK, Gershenson DM. Sood AK, et al. Expert Opin Pharmacother. 2005 Jun;6(7):1269-75. doi: 10.1517/14656566.6.7.1269. Expert Opin Pharmacother. 2005. PMID: 15957979 No abstract available.

6

Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary.

Bonome T, Lee JY, Park DC, Radonovich M, Pise-Masison C, Brady J, Gardner GJ, Hao K, Wong WH, Barrett JC, Lu KH, Sood AK, Gershenson DM, Mok SC, Birrer MJ. Bonome T, et al. Among authors: sood ak. Cancer Res. 2005 Nov 15;65(22):10602-12. doi: 10.1158/0008-5472.CAN-05-2240. Cancer Res. 2005. PMID: 16288054

7

Preoperative serum tissue factor levels are an independent prognostic factor in patients with ovarian carcinoma.

Han LY, Landen CN Jr, Kamat AA, Lopez A, Bender DP, Mueller P, Schmandt R, Gershenson DM, Sood AK. Han LY, et al. Among authors: sood ak. J Clin Oncol. 2006 Feb 10;24(5):755-61. doi: 10.1200/JCO.2005.02.9181. Epub 2005 Dec 27. J Clin Oncol. 2006. PMID: 16380413

8

Stress hormone-mediated invasion of ovarian cancer cells.

Sood AK, Bhatty R, Kamat AA, Landen CN, Han L, Thaker PH, Li Y, Gershenson DM, Lutgendorf S, Cole SW. Sood AK, et al. Clin Cancer Res. 2006 Jan 15;12(2):369-75. doi: 10.1158/1078-0432.CCR-05-1698. Clin Cancer Res. 2006. PMID: 16428474 Free PMC article.

9

The clinical relevance of stromal matrix metalloproteinase expression in ovarian cancer.

Kamat AA, Fletcher M, Gruman LM, Mueller P, Lopez A, Landen CN Jr, Han L, Gershenson DM, Sood AK. Kamat AA, et al. Among authors: sood ak. Clin Cancer Res. 2006 Mar 15;12(6):1707-14. doi: 10.1158/1078-0432.CCR-05-2338. Clin Cancer Res. 2006. PMID: 16551853 Free PMC article.

10

The BRK tyrosine kinase is expressed in high-grade serous carcinoma of the ovary.

Schmandt RE, Bennett M, Clifford S, Thornton A, Jiang F, Broaddus RR, Sun CC, Lu KH, Sood AK, Gershenson DM. Schmandt RE, et al. Among authors: sood ak. Cancer Biol Ther. 2006 Sep;5(9):1136-41. doi: 10.4161/cbt.5.9.2953. Epub 2006 Sep 28. Cancer Biol Ther. 2006. PMID: 16855388

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,157 results

Search Page

Filters